Directions in Oncology Pharmacy ® 2019
Directions in Oncology Pharmacy 2019 will provide education to pharmacists practicing in the oncology clinic, hospital, and specialty pharmacy settings.
Integration of PARP Inhibitors for the Treatment of Ovarian Cancer: Significance for Payers and Specialty Pharmacies
This program will analyze approved PARP inhibitor therapies for ovarian cancer through applied knowledge of clinical trial data, mechanisms of action, and adverse effect profiles.
Chronic Lymphocytic Leukemia: Evolving Treatment Strategies and the Role of the Specialty Pharmacist in Improving Patient Outcomes
This free CE will explain the role of the pharmacist in improving adherence and disease outcomes in patients receiving CLL therapy.
Therapy Options for the Optimal Care of Patients with Multiple Myeloma (On-Demand Webinar)
This program will explore current and emerging treatments of MM, including preferred combination regimens and management of therapy-induced adverse effects.